Modern Drug Trends in the United States



Addiction is a rapidly evolving field, with new substances, trends, industries, and treatment paradigms constantly emerging.  This webinar will cover all the most relevant trends healthcare professionals need to know, including updates on opioids and fentanyl, high-potency marijuana and THC concentrates, kratom, and microdosing psychedelics.


  • Describe the current state of the opioid epidemic in America, and current initiatives to reduce addiction and mortality.
  • Accurately describe the risks of marijuana and THC use, as well as how the industry has shaped public understanding of these issues.
  • Describe the psychotropic properties of kratom and the complexities related to its legality.
  • Understand the practice of microdosing, and the current state of research related to microdosing practices.
Target Audience: Psychologists, Social Workers, Addiction Counselors, & Licensed Professional Counselors
Content level: Beginner to intermediate
2 CE hour credits approved by ASWB, NAADAC & NBCC
State Board Approval
ADACBGA # 19-12-17-1212
FCB # 5387-A
OCDP BOARD # 50-29024

Course Features

  • Lectures 2
  • Quizzes 1
  • Duration 2 hours
  • Skill level Intermediate to Advanced
  • Language English
  • Students 11
  • Certificate Yes
  • Assessments Self
    • Lecture.1
      Modern Drug Trends in the United States
    • Lecture.1
      Modern Drug Trends in the United States
  • QUIZ
    • Quiz.1
      Modern Drug Trends in the United States 15 questions

Aaron Weiner, PhD, ABPP is a board-certified Psychologist and addiction specialist, and speaks nationally on the topics of addiction, behavioral health, and the impact of drug policy on public health. He earned his doctorate from the University of Illinois at Urbana-Champaign and completed his fellowship in Addiction Psychology at the VA Ann Arbor Healthcare System. His perspective is informed by his years of experience growing and directing addiction service lines for healthcare systems, the current state of medical and psychological research, and his own observations in private practice. He is a strong advocate for evidence-based care in treating chemical dependency and behavioral addictions, as well as a proponent of integrating behavioral health services into medical settings. Dr. Weiner is a member of the Physician Speakers Bureau for the National Safety Council, the Science Advisory Board for Smart Approaches to Marijuana, and a former Board Member for the Society of Addiction Psychology.